Scott T Moe

Title: Scott T Moe: Innovator in Pharmaceutical Chemistry

Introduction

Scott T Moe is a notable inventor based in Marlborough, MA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications.

Latest Patents

Scott T Moe holds two patents that showcase his innovative work. His first patent involves substituted azetidinones, which are compounds designed to inhibit various enzymes such as tryptase, thrombin, and Factor Xa. These compounds are particularly useful in preventing and treating conditions like asthma, chronic asthma, allergic rhinitis, and thrombotic disorders. His second patent focuses on heterocyclic compounds that act as D-alanyl-D-alanine ligase inhibitors. These compounds possess antibacterial properties and are critical in bacterial cell-wall synthesis, making them suitable for various antibacterial applications.

Career Highlights

Throughout his career, Scott T Moe has worked with reputable companies, including Daimed and Pliva D.d. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Scott has collaborated with notable individuals in his field, including Manuel A Navia and Thomas D Bannister. These collaborations have likely enhanced his research and development efforts.

Conclusion

Scott T Moe is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in therapeutic compounds. His patents reflect his commitment to innovation and improving healthcare outcomes.